title: Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
authors.affiliation: University of Pavia, Pavia, Italy giuseppe.derosa@unipv.it.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Derosa
authors.affiliation: University of Pavia, Pavia, Italy giuseppe.derosa@unipv.it.
authors.forename: Pamela
authors.initials: P
authors.lastname: Maffioli
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D000789:Angina, Unstable / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D014498:Uracil / Q000031:analogs & derivatives*; D000097789:Glucagon-Like Peptide-1 Receptor Agonists
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D010455:Peptides; D010880:Piperidines; D014498:Uracil; D000097789:Glucagon-Like Peptide-1 Receptor Agonists